Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
KYMR
KYMR News & Events
-
Add to Watchlist
Trade KYMR
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
KYMR News
Key Wall Street Rating Changes Overview
4d ago
CNBC
Kymera Therapeutics Q1 2026 Earnings Call Insights
Apr 30 2026
seekingalpha
Kymera Therapeutics Q1 Earnings Announcement Scheduled
Apr 29 2026
seekingalpha
Kymera's KT-621 Receives FDA Fast Track Designation
Apr 13 2026
NASDAQ.COM
Kymera Therapeutics' KT-621 Receives FDA Fast Track Designation
Apr 13 2026
Newsfilter
KYMERA THERAPEUTICS INC - GILEAD TO PROGRESS KT-200 INTO STUDIES PREPARING FOR IND FILING IN 2027
Apr 09 2026
moomoo
KYMERA THERAPEUTICS REVEALS GILEAD SCIENCES HAS EXERCISED OPTION TO LICENSE KT-200, AN ORAL CDK2 MOLECULAR GLUE DEGRADER CANDIDATE
Apr 09 2026
moomoo
Nextech Reduces Stake in Kymera Therapeutics: Analysis
Mar 19 2026
NASDAQ.COM
Show More News
KYMR Events
No data
KYMR Monitor News
Kymera Therapeutics Reports Strong Q4 Progress and New Partnerships
Feb 26 2026
Kymera Therapeutics Hits 52-Week High on KT-621 Trial Results
Dec 08 2025
KYMR Earnings Analysis
No Data
People Also Watch
